
Benjamin Stecher
@neuronologist1
Author of Reprogramming The Brain and Brain Fables
ID: 773193444504240128
http://tmrwedition.com 06-09-2016 16:17:37
5,5K Tweet
3,3K Followers
1,1K Following


New clinical trial registered: Gain Therapeutics have a Phase 1b, 3-month, multicenter, open-label study in Australia of GT-02287 (an allosteric regulator of GCase) in 20 participants with #Parkinsons with or without GBA1 mutations clinicaltrials.gov/study/NCT06732ā¦




Declining incidence of #Parkinsons in Germany via Journal of Parkinson's Disease journals.sagepub.com/doi/full/10.11ā¦

To all postdocs and PIs interested in pursuing research into GBA-PD, you have 1 month to get your applications in for the Silverstein Foundation Fellowship Program. Join this amazing group of researchers pushing boundaries on what we know about GBA-PD... tmrwedition.com/2024/12/16/theā¦

Niko McCarty. I think this is a real interesting space, especially if you think about cell bodies are relatively stable in size, but the total volume/surface are of some cells scales pretty insanely. Here's a thought on neurons :



Are you waiting months to see a neurologist? If you are navigating Alzheimer's, Parkinson's, Huntington's or ALS, our doctors are available within weeks. Appointments still available for March. Synapticure




How does physics inform neurodegeneration? Supersaturation lowers the nucleation barrier for the precipitation of monomeric proteins into their pathological state. In normal aging, replacement matches loss; in accelerated aging, it does not. (1/4) onlinelibrary.wiley.com/doi/10.1002/biā¦

"We suggest this search is in vain. The problem lies not in the population but in the framework itself" Shots fired! Alberto J Espay & colleagues ask probing questions regarding αSyn-SAA-based staging for #Parkinsons progression ā¦mentdisorders.onlinelibrary.wiley.com/doi/10.1002/mdā¦